Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
3
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
3
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aducanumab
cancer
cancer immunotherapy
car-t immunotherapy
celgene
clinical trials
deals
eli lilly
genentech
johnson & johnson
merck
What
bio
drug
3
×
news
3
×
roundup
approved
companies
nash
adu
approval
beats
bids
biogen
biogen’s
biopharmaceutical
complicated
convo
depression
digital
dire
disease
earlier
epidemic
failures
fatty
fda
frenzied
good
group
growing
heart
help
known
led
littered
liver
medical
merck
need
new
people
Language
Current search:
drug
×
biotech
×
" detroit blog main "
×
" new york blog main "
×
news
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More